Glioblastoma therapeutics market to double in APAC by 2020

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 2 Comment | 19 Sep, 2014

Singapore: Glioblastoma multiforme (GBM) therapeutics market in Asia-Pacific (APAC) is estimated to grow double from USD...Read more

Re-engineered antibiotic could fight drug-resistant bacteria

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2015

The US scientists have created a promising second-generation antibiotic to fight against the bacteria that commonly caus...Read more

Anti-herpes drug may help control HIV: NIH

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2015

Singapore: Valacyclovir, a drug indicated to control the virus that causes genital herpes, appears to reduce the levels ...Read more

FDA approves single dosage HIV drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Aug, 2014

Singapore: The US Food and Drug Administration (FDA) has approved US-based ViiV Healthcare's single dose Triumeq tablet...Read more

DNA repair drug could treat leukaemia: Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Aug, 2014

Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designe...Read more

Abivax initiates Ph IIa clinical trial of HIV drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2015

Singapore: Abivax, a leading clinical stage biotech company developing and commercializing anti-viral compounds and huma...Read more

Eisai UK site to make epilepsy drug for US

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Sep, 2013

Singapore: Japan-based Eisai recieved US FDA approval for the US supply of the epilepsy drug Fycompa (perampanel) from i...Read more

J&J neuro R&D head uses street drug to treat depression

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2013

Singapore: Johnson & Johnson (J&J) is contemplating the thought of treating depression using popular street drug...Read more

FDA's call on Rytary delayed by 3 months

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2014

Singapore: Impax laboratories in Taiwan recently announced that FDA had delayed its decision on Rytary, the first non-ge...Read more

Hironic to begin world's first HIFU Urinary Incontinence treatment study in Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jun, 2016

Singapore: Hironic, based out of Seoul, Korea, is an innovator of medical aesthetic laser and energy devices. The compan...Read more

Japanese GHIT Fund to include diagnostics and drugs for leishmaniasis

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2015

The Global Health Innovative Technology Fund (GHIT Fund) of Japan, which in the last two years has funded almost $32 mil...Read more

ASLAN raises $43 mn in series C financing round

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2016

Singapore: ASLAN Pharmaceuticals, Singapore based biotech company focused on the development of immunotherapies and targ...Read more

New drug formulation for respiratory system infections

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2014

Singapore: A team from A*STAR's Institute of Chemical and Engineering Sciences (ICES) and National University Hospital (...Read more

Novartis finds no evidence of wrongdoing in clinical trials

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

Singapore: Novartis Pharma KK has found no evidence that data on clinical trials for its hypertension drug Diovan had be...Read more

BI, Lilly's diabetes drug Linagliptin shows efficacy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

Singapore: Boehringer Ingelheim and Eli Lilly's investigational Type 2 Diabetes (T2D) drug dipeptidyl peptidase-4 (DPP-4...Read more

Actavis 'pregnancy preventer' gets FDA nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2013

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch ...Read more

Aussie firm Phosphagenics raises $11.45 mn

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2014

Singapore: Australian drug delivery company, Phosphagenics, has raised $11.45 million of its $15.29 million capital rais...Read more

Patrys gets nod to progress myeloma trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2013

Singapore: Patrys, Australia's clinical stage biopharmaceutical company, has received approval to progress its phase I/I...Read more